-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $5.25

Benzinga·02/28/2025 23:57:51
Listen to the news
Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE:BLND) with a Buy and lowers the price target from $5.75 to $5.25.